《嘉德诺Cardinal Health（CAH）2023财年第二季度财报（英文版）（15页）.pdf》由会员分享，可在线阅读，更多相关《嘉德诺Cardinal Health（CAH）2023财年第二季度财报（英文版）（15页）.pdf（15页珍藏版）》请在三个皮匠报告上搜索。

1、Exhibit 99.1 FOR IMMEDIATE RELEASE Cardinal Health Reports Second Quarter Fiscal Year 2023 Results and Raises Fiscal Year 2023 Non-GAAP EPS Guidance Revenue increased 13%to$51.5 billion GAAP1 operating loss was$119 million due to a non-cash,pre-tax goodwill impairment of$709 million related to the M

2、edical segment;GAAP diluted loss per share was$0.50 Non-GAAP operating earnings of$467 million were in-line with the second quarter of last year;non-GAAP diluted EPS increased 4%to$1.32 Fiscal year 2023 non-GAAP EPS guidance raised to$5.20 to$5.50,from$5.05 to$5.40 DUBLIN,Ohio,February 2,2023 Cardin

3、al Health(NYSE:CAH)today reported second quarter fiscal year 2023 revenues of$51.5 billion,an increase of 13%from the second quarter of fiscal year 2022.Second quarter GAAP operating loss was$119 million due to a non-cash,pre-tax goodwill impairment of$709 million related to the Medical segment.GAAP

4、 diluted loss per share was$0.50,primarily due to this impairment,net of tax effects.Second quarter non-GAAP operating earnings of$467 million were in-line with the second quarter of last year.Non-GAAP diluted earnings per share(EPS)increased 4%to$1.32,due to lower interest expense and a lower share

5、 count,partially offset by a higher non-GAAP effective tax rate.Our second quarter results demonstrate continued momentum against our plans,led by better-than-expected performance in the Pharmaceutical segment and Medical results in-line with our prior commentary,”said Jason Hollar,CEO of Cardinal H

6、ealth.With the first half of fiscal year 2023 behind us,we are pleased to raise our full year non-GAAP EPS guidance and outlook for the Pharmaceutical segment.In the Medical segment,we remain confident in our Medical Improvement Plan,including the actions we are taking to mitigate supply chain infla